Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
26 Prestige Biopharma IDC to Host First International Symposium on Emerging Biopharmaceutical Modalities
김** | 2024.11.15 | Votes 0 | Views 331
김** 2024.11.15 0 331
25 Prestige Biopharma IDC Opens New Innovative Discovery Center in Busan
김** | 2024.11.15 | Votes 0 | Views 497
김** 2024.11.15 0 497
24 Prestige Biopharma IDC CEO Sang-Seok Koh Receives Presidential Commendation
we******** | 2024.11.06 | Votes 0 | Views 348
we******** 2024.11.06 0 348
23 Prestige Biopharma IDC and Aptis Sign Collaboration for Next-Generation ADC Cancer Therapy Development
we******** | 2024.09.26 | Votes 0 | Views 360
we******** 2024.09.26 0 360
22 Prestige Biopharma Receives European Commission Approval for Herceptin Biosimilar Tuznue®
we******** | 2024.09.23 | Votes 0 | Views 637
we******** 2024.09.23 0 637
21 Prestige Biopharma Group Participates in BIO USA 2024 Exhibition
김** | 2024.06.16 | Votes 0 | Views 751
김** 2024.06.16 0 751
20 Prestige Biopharma IDC Appoints Dr. Koh Sang-seok, Discoverer of PAUF Protein, as CEO
김** | 2024.03.05 | Votes 0 | Views 352
김** 2024.03.05 0 352
19 Prestige Biopharma Explores Global Expansion of PAUF-Based Pancreatic Cancer Diagnostic Kit at MEDICA 2023
we******** | 2023.11.16 | Votes 0 | Views 315
we******** 2023.11.16 0 315
18 Prestige Biopharma Secures Chinese Patent for PBP1510, a First-in-Class Anti-PAUF Antibody for Pancreatic Cancer
we******** | 2023.11.07 | Votes 0 | Views 459
we******** 2023.11.07 0 459
17 Prestige Biopharma Group Signs Strategic CDMO Partnership with Dr. Reddy’s Laboratories
김** | 2023.09.22 | Votes 0 | Views 536
김** 2023.09.22 0 536